We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.
Sources of formaldehyde, other aldehydes and terpenes in a new manufactured house.
Indoor Air 2002 December
Formaldehyde, less volatile aldehydes, and terpene hydrocarbons are generally the predominant air contaminants in new manufactured and site-built houses. This study was conducted to identify the major sources of these compounds in a typically constructed, new manufactured house and to evaluate several source reduction practices. Specimens of materials used within the house were collected. These were individually pre-conditioned for 19 +/- 4 days, and tested for emissions of formaldehyde and other target compounds using small-scale chambers. Several cabinetry materials, passage doors, and the plywood subfloor were the predominant sources of formaldehyde and other aldehydes. The plywood subfloor was the predominant terpene source. Whole-house emission rates for combined materials were predicted based on the emission factors and the corresponding material quantities. These predicted rates were compared with whole-house emission rates derived from measurements made at the house 3 months after its installation. For 10 of 14 target compounds including formaldehyde, the predicted and derived rates were within a factor of two. Four emission barriers applied to plywood were shown to reduce emission factors for formaldehyde, hexanal, and other aldehydes.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app